Vaccine stocks have struggled since RFK Jr.'s appointment to health secretary, with Moderna and Pfi…

Moderna lowered its annual sales forecast as sales of its COVID-19 vaccine dropped by 37%, fueled b…

Stock indexes tanked Thursday as new data shows jobless claims are on the rise while manufacturing …

A third dose of Moderna's booster vaccine resulted in a 37-fold increase in antibody protection aga…

The patents subject to the court's ruling cover a lipid formulation for nucleic acid delivery, whic…

The stock prices of vaccine makers Moderna and Pfizer surged Friday along with stay-at-home stocks …

"If we have to make a brand new vaccine, I think that's going to be early 2022 before that's really…

The antiviral drug could put a dent into the uptake of COVID-19 vaccines, as countries still strugg…

The drugmaker expects 2022 revenue of $98 billion to $102 billion, which fell below analyst expecta…

The vaccine mandate was aimed at private companies with more than 100 employees. The ruling upheld …

Year-to-date, shares of BioNTech, Moderna, and Pfizer have surged 357%, 275%, and 28%, respectively.

"To justify $200 billion in value, one has to assume 1 to 1.5 billion doses of COVID-19 vaccine eac…

Moderna, the almost 11 year old company that created a 95% effective pandemic ending vaccine in les…

Alexion Therapeutics, which is set to be acquired by AstraZeneca, will be replaced by Moderna in th…

Big-name investors have moved quickly to dump stock shares amid this year's rally, with the S&P 500…

The pharma giant said combining its cancer vaccine with Merck's Keytruda therapy reduced patients' …

The CDC's guidance to pause the use of J&J's COVID vaccine came following reports of 6 rare blood c…

The EU's drug regulator is looking at reports about skin rash and kidney problems.

Moderna and Johnson & Johnson's vaccines are approved for adults over 18, while the vaccine from Pf…